ORBIMED ADVISORS LLC 13D and 13G filings for Disc Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-12 7:57 pm Sale |
2025-03-10 | 13D | Disc Medicine, Inc. IRON |
ORBIMED ADVISORS LLC | 1,556,369 4.500% |
-229,202 (-12.84%) |
Filing |
| 2024-06-20 5:15 pm Purchase |
2024-06-17 | 13D | Disc Medicine, Inc. IRON |
ORBIMED ADVISORS LLC | 1,785,571 6.000% |
83,334 (+4.90%) |
Filing |
| 2023-12-15 4:48 pm Sale |
2023-12-13 | 13D | Disc Medicine, Inc. IRON |
ORBIMED ADVISORS LLC | 1,702,237 7.100% |
-567,400 (-25.00%) |
Filing |
| 2023-06-21 4:53 pm Purchase |
2023-06-16 | 13D | Disc Medicine, Inc. IRON |
ORBIMED ADVISORS LLC | 2,269,637 10.200% |
108,696 (+5.03%) |
Filing |
| 2023-01-03 5:23 pm Purchase |
2022-12-29 | 13D | Disc Medicine, Inc. IRON |
ORBIMED ADVISORS LLC | 2,160,941 12.800% |
2,160,941 (New Position) |
Filing |